<ENAMEX TYPE="ORGANIZATION">Imperial Chemical Industries PLC</ENAMEX>, a major British chemicals and pharmaceuticals concern, said pretax profit in the first nine months of the year rose 9% on growth in pharmaceutical sales.
Pretax profit rose to # 1.23 billion ($1.99 billion) from # 1.13 billion in the year-earlier period. The company's pretax profit, however, was hit particularly hard by soft returns in <ENAMEX TYPE="LOCATION">ICI</ENAMEX>'s petrochemical and plastics operations during the third quarter.
Third-quarter pretax profit dropped 12% to # 306 million from # 347 million in the 1988 period, <ENAMEX TYPE="ORGANIZATION">ICI</ENAMEX> said. The results for the third quarter and nine months were worse than expected.
<ENAMEX TYPE="ORGANIZATION">ICI</ENAMEX> said its nine-month profit after tax, or net profit attributable to shareholders, rose 18% to # 744 million from # 632 million in the year-earlier period. Per-share earnings increased 9% to 108.3 pence ($1.75) from 99.7 pence.
